sarcoma

You have access
Comparison of [⁶⁸Ga]Ga-Fibroblast Activation Protein Inhibitor–04 and [¹⁸F]FDG PET Imaging for Solitary Fibrous Tumor and Preliminary Application of FAP-Targeted Radiopharmaceutical Therapy
Rongxi Wang, Jiarou Wang, Jialin Xiang, Huimin Sui, Linlin Li, Chenhao Jia, Xingtong Peng, Xiaoyuan Chen, Zhaohui Zhu and Jingjing Zhang

Journal of Nuclear Medicine April 1, 2025, 66 (4) 585-591; DOI: https://doi.org/10.2967/jnumed.124.268258
You have access
⁶⁸Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy
Helena Lanzafame, Ilektra A. Mavroeidi, Kim M. Pabst, Mélanie Desaulniers, Marc Ingenwerth, Nader Hirmas, Lukas Kessler, Michael Nader, Timo Bartel, Stephan Leyser, Francesco Barbato, Martin Schuler, Sebastian Bauer, Jens T. Siveke, Ken Herrmann, Rainer Hamacher and Wolfgang P. Fendler

Journal of Nuclear Medicine June 1, 2024, 65 (6) 880-887; DOI: https://doi.org/10.2967/jnumed.123.267248
You have access
Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous Tumor
Rainer Hamacher, Kim M. Pabst, Phyllis F. Cheung, Christoph E. Heilig, Jennifer Hüllein, Sven-Thorsten Liffers, Sabrina Borchert, Pedro Fragoso Costa, Benedikt M. Schaarschmidt, Lukas Kessler, Monika A. Miera, Margret Droste, Merve Akbulut, Johanna Falkenhorst, Fadi Zarrad, Karina Kostbade, Ilektra A. Mavroeidi, Hanno Glimm, Lale Umutlu, Martin Schuler, Daniel Hübschmann, Sebastian Bauer, Stefan Fröhling, Ken Herrmann, Jens T. Siveke, Hans-Ulrich Schildhaus and Wolfgang P. Fendler

Journal of Nuclear Medicine February 1, 2024, 65 (2) 252-257; DOI: https://doi.org/10.2967/jnumed.123.266411
You have access
[¹⁸F]FDG PET/CT in the Initial Staging and Restaging of Soft-Tissue or Bone Sarcoma in Patients with Negative or Equivocal Findings for Metastases or Limited Recurrence on Conventional Work-up: Results of a Prospective Multicenter Registry
Ur Metser, Roshini Kulanthaivelu, Abdulazeez Salawu, Albiruni Razak, Victor Mak, Xuan Li, Deanna L. Langer, Pamela MacCrostie and Amit Singunkar

Journal of Nuclear Medicine September 1, 2023, 64 (9) 1371-1377; DOI: https://doi.org/10.2967/jnumed.122.265278
You have access
¹⁸F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
Joseph G. Crompton, Wesley R. Armstrong, Mark A. Eckardt, Ameen Seyedroudbari, William D. Tap, Sarah M. Dry, Evan R. Abt, Jeremie Calais, Ken Herrmann, Johannes Czernin, Fritz C. Eilber and Matthias R. Benz

Journal of Nuclear Medicine May 1, 2022, 63 (5) 708-712; DOI: https://doi.org/10.2967/jnumed.121.262502
You have access
⁶⁸Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the ⁶⁸Ga-FAPI PET Prospective Observational Trial
Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Sebastian Bauer, Uta Dirksen, Fadi Zarrad, Michael Nader, Michal Chodyla, Aleksandar Milosevic, Lale Umutlu, Martin Schuler, Lars Erik Podleska, Hans-Ulrich Schildhaus, Wolfgang P. Fendler and Rainer Hamacher

Journal of Nuclear Medicine January 1, 2022, 63 (1) 89-95; DOI: https://doi.org/10.2967/jnumed.121.262096
You have access
Response to Early Treatment Evaluated with ¹⁸F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor
Joo Hyun O, Brandon S. Luber, Jeffrey P. Leal, Hao Wang, Vanessa Bolejack, Scott M. Schuetze, Lawrence H. Schwartz, Lee J. Helman, Denise Reinke, Laurence H. Baker and Richard L. Wahl

Journal of Nuclear Medicine May 1, 2016, 57 (5) 735-740; DOI: https://doi.org/10.2967/jnumed.115.162412

Main menu

User menu

Search

sarcoma